rs907041830
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP5
The NM_003907.3(EIF2B5):c.1010A>G(p.His337Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 31)
Consequence
EIF2B5
NM_003907.3 missense
NM_003907.3 missense
Scores
1
12
6
Clinical Significance
Conservation
PhyloP100: 8.89
Genes affected
EIF2B5 (HGNC:3261): (eukaryotic translation initiation factor 2B subunit epsilon) This gene encodes one of five subunits of eukaryotic translation initiation factor 2B (EIF2B), a GTP exchange factor for eukaryotic initiation factor 2 and an essential regulator for protein synthesis. Mutations in this gene and the genes encoding other EIF2B subunits have been associated with leukoencephalopathy with vanishing white matter. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_003907.3
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-184140584-A-G is Pathogenic according to our data. Variant chr3-184140584-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 590971.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EIF2B5 | NM_003907.3 | c.1010A>G | p.His337Arg | missense_variant | 7/16 | ENST00000648915.2 | |
EIF2B5 | XM_047449148.1 | c.1010A>G | p.His337Arg | missense_variant | 7/11 | ||
EIF2B5 | XM_011513265.1 | c.260A>G | p.His87Arg | missense_variant | 3/12 | ||
EIF2B5 | XM_011513266.4 | c.173A>G | p.His58Arg | missense_variant | 2/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EIF2B5 | ENST00000648915.2 | c.1010A>G | p.His337Arg | missense_variant | 7/16 | NM_003907.3 | P2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Vanishing white matter disease Pathogenic:1
Likely pathogenic, criteria provided, single submitter | research | Consultorio y Laboratorio de Neurogenética, Hospital JM Ramos Mejia | Oct 29, 2018 | The variant identified not been previously reported in public databases. This variant was identified in a patient diagnosed with Vanishing white matter leukodystrophy, a disease characterized by variable neurologic features, including progressive cerebellar ataxia, spasticity, and cognitive impairment associated with white matter lesions on brain imaging. We consider that these variants in compound heterozygosis are probably pathogenic because they are in a critical region and coding for the EIF2B5 gene; The gene has previously been associated with this disease as reported in the OMIM database and PubMed (Sharma et al., 2015; Woody et al., 2015). - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 24, 2024 | Variant summary: EIF2B5 c.1010A>G (p.His337Arg) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251454 control chromosomes. c.1010A>G has been reported in the literature in compound heterozygous individuals affected with Leukoencephalopathy With Vanishing White Matter, including two affected individuals in one family (Rodrguez-Quiroga_2015, Cohen_2020, Benzoni_2023). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 37171481, 31418856, 25989649). ClinVar contains an entry for this variant (Variation ID: 590971). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;.
REVEL
Uncertain
Sift
Benign
T;.;.
Sift4G
Benign
T;.;.
Polyphen
P;.;P
Vest4
MutPred
Gain of sheet (P = 0.0477);.;Gain of sheet (P = 0.0477);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at